SEP 21, 2016 12:24 PM PDT

How Space Exploration is Supporting Cancer Discoveries

WRITTEN BY: Xuan Pham
Cancer biologists have a surprising but wholly vested ally in the National Aeronautics and Space Administration (NASA). The partnership began 15 years ago and has recently been renewed for continued collaboration between the Jet Propulsion Laboratory and the National Cancer Institute (NCI) until 2021.
 The Same technology that scans galaxies also works to scan for cancer! | Image: Early Research Detection Network
How did this unlikely friendship start? As it turns out, both NASA and cancer researchers deal with mass quantities of data that may be managed or mined with the same computer algorithms. For NASA, the raw data are often in the form of measurements from cameras, spectrometers, and other sensors. For cancer biologists, the data are often physical measurements of metabolites, proteins, and other biomarkers. The same tool, then, that allows physicists to study a star, planet, or any celestial system could be applied to biology, helping researchers hone in cancer systems.
 
"From a NASA standpoint, there are significant opportunities to develop new data science capabilities that can support both the mission of exploring space and cancer research using common methodological approaches," said Dan Crichton who heads JPL's Center for Data Science and Technology. "We have a great opportunity to perfect those techniques and grow JPL's data science technologies, while serving our nation.

The partnership has resulted in six chemicals and genetic biomarkers that were FDA-approved for use in cancer research and diagnosis worldwide. An additional nine biomarkers are approved for use in clinical labs in the US.
 

Next, the collaborators hope to apply image-recognition software used to spot star clusters and other celestial bodies to improve cancer discoveries. In particular, this software could help archive images of cancer specimen from the EDRN. Then, the images can be analyzed for early signs of cancer based on a patient's age, ethnic background, and other demographics.
 
"As we develop more automated methods for detecting and classifying features in images, we see great opportunities for enhancing data discovery," said Crichton. "We have examples where algorithms for detection of features in astronomy images have been transferred to biology and vice-versa."

Additional source: NASA, Nature World News, Space.com
About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
SEP 06, 2021
Drug Discovery & Development
Antibiotics Increase Colon Cancer Risk by 17%
SEP 06, 2021
Antibiotics Increase Colon Cancer Risk by 17%
People who take antibiotics are at an increased risk of developing colon cancer within five to ten years. The research w ...
OCT 04, 2021
Cancer
Predicting Progression-Free Survival in a Melanoma Study
OCT 04, 2021
Predicting Progression-Free Survival in a Melanoma Study
IsoPlexis’ Single-Cell Proteomics Predict Progression-Free Survival in Melanoma Study While advancements in oncolo ...
SEP 27, 2021
Cancer
Inflammation Promotes Pancreatic Cancer Progression
SEP 27, 2021
Inflammation Promotes Pancreatic Cancer Progression
Inflammation occurs when the immune response, including immune cells and mediators they produce, protect you from danger ...
OCT 14, 2021
Clinical & Molecular DX
Weighing Cancer Cells Helps Predict Treatment Outcomes
OCT 14, 2021
Weighing Cancer Cells Helps Predict Treatment Outcomes
Not all cancer patients respond to oncology treatments in the same way. Some might show signs of improvement as the ther ...
NOV 17, 2021
Cancer
Turkey, Tryptophan, and Cancer
NOV 17, 2021
Turkey, Tryptophan, and Cancer
As many people start to plan their Thanksgiving dinners, there will inevitably be a lot of talk about the turkey.  ...
DEC 03, 2021
Drug Discovery & Development
FDA approves new imaging drug to make ovarian cancer tumors glow.
DEC 03, 2021
FDA approves new imaging drug to make ovarian cancer tumors glow.
Earlier this week, the United States Food and Drug Administration (FDA) announced its approval for a novel dru ...
Loading Comments...